In the management of acute myeloid leukemia, what is the role of supportive care?

• A. To manage complications and support recovery
• B. To replace chemotherapy entirely
• C. To serve as the only treatment
• D. To delay treatment indefinitely

Answer: (A)

Supportive care in AML focuses on preventing and treating the complications that arise from the disease and its treatment, so patients can actually receive and recover from chemotherapy. This means preventing infections during periods of neutropenia, promptly treating fevers with appropriate antibiotics, and using antifungal prophylaxis in high-risk cases. It also involves transfusion support to manage anemia and low platelets—red blood cell transfusions to maintain adequate oxygen delivery and platelet transfusions to reduce bleeding risk. Additional elements include managing tumor lysis risk with hydration and uric acid–lowering therapy, controlling pain and nausea, ensuring good nutrition, and monitoring organ function to keep patients stable enough to continue therapy. Growth factors may be used in some regimens to shorten the duration of neutropenia, but they do not treat the leukemia themselves. In short, supportive care reduces complications and helps the patient endure and recover from the disease-directed treatment.